Joshua F Baker1, Grant W Cannon2, Said Ibrahim2, Candace Haroldsen2, Liron Caplan2, Ted R Mikuls2. 1. From the Division of Rheumatology, and Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs (VA) Medical Center; Division of Rheumatology, and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Salt Lake City VA Medical Center and University of Utah, Salt Lake City, Utah; Department of Medicine, Denver VA Medical Center, Denver, Colorado; Department of Medicine, Nebraska-Western Iowa VA Medical Center, Omaha, Nebraska, USA.J.F. Baker, MD, MSCE, Division of Rheumatology, Philadelphia VA Medical Center, and Division of Rheumatology, and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania; G.W. Cannon, MD, Salt Lake City VA Medical Center and University of Utah; S. Ibrahim, MD, MPH, Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, and Perelman School of Medicine, University of Pennsylvania; C. Haroldsen, MSPH, Salt Lake City VA Medical Center and University of Utah; L. Caplan, MD, PhD, Department of Medicine, Denver VA Medical Center; T.R. Mikuls, MD, MSPH, Department of Medicine, Nebraska-Western Iowa VA Medical Center. bakerjo@uphs.upenn.edu. 2. From the Division of Rheumatology, and Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs (VA) Medical Center; Division of Rheumatology, and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Salt Lake City VA Medical Center and University of Utah, Salt Lake City, Utah; Department of Medicine, Denver VA Medical Center, Denver, Colorado; Department of Medicine, Nebraska-Western Iowa VA Medical Center, Omaha, Nebraska, USA.J.F. Baker, MD, MSCE, Division of Rheumatology, Philadelphia VA Medical Center, and Division of Rheumatology, and Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania; G.W. Cannon, MD, Salt Lake City VA Medical Center and University of Utah; S. Ibrahim, MD, MPH, Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, and Perelman School of Medicine, University of Pennsylvania; C. Haroldsen, MSPH, Salt Lake City VA Medical Center and University of Utah; L. Caplan, MD, PhD, Department of Medicine, Denver VA Medical Center; T.R. Mikuls, MD, MSPH, Department of Medicine, Nebraska-Western Iowa VA Medical Center.
Abstract
OBJECTIVE: Low body mass index (BMI) is a risk factor for poor longterm outcomes in rheumatoid arthritis (RA). The purpose of this study was to identify factors associated with longterm changes in BMI. METHODS: Subjects with RA from the Veterans Affairs (VA) Rheumatoid Arthritis (VARA) Registry (n = 1474) were studied. Information on inflammatory markers, presence of erosions, and smoking status were extracted from the VARA database. BMI was extracted from VA electronic medical records within 14 days of each visit date. VA pharmacy records were queried to identify prescriptions for specific RA therapies within 1 month of the visit date. We used robust generalized estimating equations marginal regression models to calculate independent associations between clinical variables and BMI over time. Similar models determined predictors of change in weight and risk of weight loss over the subsequent study observation period. RESULTS: Increasing age, active smoking, and the presence of erosions at baseline were associated with lower BMI. Weight decreased over time among older adults. Factors associated with greater reductions in BMI over time and a greater risk of weight loss were higher inflammatory markers, smoking, older age, higher BMI, and less subsequent improvement in inflammation. Methotrexate use was associated with a lower risk of weight loss. The use of prednisone or anti-tumor necrosis factor therapies was not associated with change in BMI or the risk of weight loss independent of other factors. CONCLUSION: Greater age, greater inflammatory activity, and active smoking are associated with greater weight loss in RA over time.
OBJECTIVE: Low body mass index (BMI) is a risk factor for poor longterm outcomes in rheumatoid arthritis (RA). The purpose of this study was to identify factors associated with longterm changes in BMI. METHODS: Subjects with RA from the Veterans Affairs (VA) Rheumatoid Arthritis (VARA) Registry (n = 1474) were studied. Information on inflammatory markers, presence of erosions, and smoking status were extracted from the VARA database. BMI was extracted from VA electronic medical records within 14 days of each visit date. VA pharmacy records were queried to identify prescriptions for specific RA therapies within 1 month of the visit date. We used robust generalized estimating equations marginal regression models to calculate independent associations between clinical variables and BMI over time. Similar models determined predictors of change in weight and risk of weight loss over the subsequent study observation period. RESULTS: Increasing age, active smoking, and the presence of erosions at baseline were associated with lower BMI. Weight decreased over time among older adults. Factors associated with greater reductions in BMI over time and a greater risk of weight loss were higher inflammatory markers, smoking, older age, higher BMI, and less subsequent improvement in inflammation. Methotrexate use was associated with a lower risk of weight loss. The use of prednisone or anti-tumor necrosis factor therapies was not associated with change in BMI or the risk of weight loss independent of other factors. CONCLUSION: Greater age, greater inflammatory activity, and active smoking are associated with greater weight loss in RA over time.
Entities:
Keywords:
BODY MASS INDEX; CACHEXIA; INFLAMMATION; RHEUMATOID ARTHRITIS
Authors: Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink Journal: Semin Arthritis Rheum Date: 2010-08 Impact factor: 5.532
Authors: Ted R Mikuls; Brian T Fay; Kaleb Michaud; Harlan Sayles; Geoffrey M Thiele; Liron Caplan; Dannette Johnson; John S Richards; Gail S Kerr; Grant W Cannon; Andreas Reimold Journal: Rheumatology (Oxford) Date: 2010-07-21 Impact factor: 7.580
Authors: Grant W Cannon; Ted R Mikuls; Candace L Hayden; Jian Ying; Jeffrey R Curtis; Andreas M Reimold; Liron Caplan; Gail S Kerr; J Steuart Richards; Dannette S Johnson; Brian C Sauer Journal: Arthritis Care Res (Hoboken) Date: 2011-12 Impact factor: 4.794
Authors: T R Mikuls; L B Hughes; A O Westfall; V M Holers; L Parrish; D van der Heijde; M van Everdingen; G S Alarcón; D L Conn; B Jonas; L F Callahan; E A Smith; G Gilkeson; G Howard; L W Moreland; S L Bridges Journal: Ann Rheum Dis Date: 2008-01-15 Impact factor: 19.103
Authors: Ted R Mikuls; Karen A Gould; Kimberly K Bynoté; Fang Yu; Tricia D Levan; Geoffrey M Thiele; Kaleb D Michaud; James R O'Dell; Andreas M Reimold; Roderick Hooker; Liron Caplan; Dannette S Johnson; Gail Kerr; J Steuart Richards; Grant W Cannon; Lindsey A Criswell; Janelle A Noble; S Louis Bridges; Laura Hughes; Peter K Gregersen Journal: Arthritis Res Ther Date: 2010-11-18 Impact factor: 5.156
Authors: Joshua F Baker; Bryant R England; Ted R Mikuls; Harlan Sayles; Grant W Cannon; Brian C Sauer; Michael D George; Liron Caplan; Kaleb Michaud Journal: Arthritis Care Res (Hoboken) Date: 2018-12 Impact factor: 4.794
Authors: Bryant R England; Joshua F Baker; Harlan Sayles; Kaleb Michaud; Liron Caplan; Lisa A Davis; Grant W Cannon; Brian C Sauer; E Blair Solow; Andreas M Reimold; Gail S Kerr; Ted R Mikuls Journal: Arthritis Care Res (Hoboken) Date: 2017-12-06 Impact factor: 4.794
Authors: Joshua F Baker; Brian C Sauer; Grant W Cannon; Chia-Chen Teng; Kaleb Michaud; Said Ibrahim; Erik Jorgenson; Lisa Davis; Liron Caplan; Amy Cannella; Ted R Mikuls Journal: Arthritis Rheumatol Date: 2016-08 Impact factor: 10.995
Authors: Richard Evans; Jennifer Burns; Laura Damschroder; Ann Annis; Michelle B Freitag; Susan Raffa; Wyndy Wiitala Journal: JMIR Med Inform Date: 2022-03-09